Titan Biotech Ltd

Fri 4/09/2026,15:27:0 | BSE : TITANBIO

₹438.002.80 (0.64%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 435.00

Previous Close

₹ 435.20

Volume

46007

Mkt Cap ( ₹ Cr)

₹ 1809.75

High

₹ 443.00

Low

₹ 423.00

52 Week High

₹ 555.65

52 Week Low

₹ 131.00

Book Value Per Share

₹ 46.23

Dividend Yield

₹ 0.00

Face Value

₹₹2.00

What's Your Call?

Collective community sentiment on Titan Biotech Ltd

Your Vote -

Buy

53.85%

Hold

19.23%

Sell

26.92%

53.85%

26 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Titan Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Titan Biotech - Intimation Of Record Date For The Purpose Of Final Dividend

    3 Sep 2026, 12:43PM Intimation of record date for the purpose of Dividend to the members of the Company for FY 2025-26.

  • Titan Biotech - Fixation Of Annual General Meeting Date, Record Date, Book Closure Date And E-Voting Date

    3 Sep 2026, 12:32PM The 34th Annual General Meeting of the Company scheduled to be held on September 29, 2026 through VC/ OAVM and the Company accordingly fixed Record Da

  • Titan Biotech - Corporate Action-Fixes Book Closure For 34Th Annual General Meeting Of The Company

    3 Sep 2026, 12:27PM Fixation of Annual General Meeting Date, Record Date, Book Closure date and dates for E-Voting

  • Titan Biotech - Corporate Action-Board recommends Bonus Issue

    3 Sep 2026, 12:22PM Recommended the Issuance of Bonus Issue, subject to shareholders approval and any other applicable regulatory and statutory approval, in the ratio of

  • Titan Biotech - Board Meeting Outcome for Outcome Of Board Meeting Dated September 3, 2026

    3 Sep 2026, 12:14PM Recommended Issuance of Bonus Shares, subject to shareholders approval and any other applicable regulatory and statutory approval, in ratio of 1:4 i.e

  • Titan Biotech - Notice Of Thirty- Fourth (34Th) Annual General Meeting

    5 Sep 2026, 3:48PM Notice of 34th Annual General Meeting of the Company scheduled to be held on Tuesday, September 29, 2026 at 03:00 P.M.(IST) through VC/OAVM

  • Titan Biotech - Reg. 34 (1) Annual Report.

    5 Sep 2026, 3:43PM 34th Annual Report of the Company for Financial Year 2025-26

  • Titan Biotech - Board Meeting Intimation for Considering Bonus Issue, Draft AGM Notice, Draft Directors Report, Fix AGM, Deci

    31 Aug 2026, 4:03PM Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 ,inter alia, to consider and ap

  • Titan Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026

    13 Aug 2026, 3:55PM Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 2026

  • Titan Biotech - Unaudited Financial Results For Quarter Ended June 2026

    13 Aug 2026, 3:48PM Unaudited Financial Results along with the limited review report from the statutory Auditor of the Company for the quarter ended June 2026

  • Titan Biotech - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Re

    5 Aug 2026, 11:34AM Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and ap

  • Titan Biotech has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    14 Jul 2026, 5:02PM As of June 2026, 55.78% is owned by Indian Promoters and 44.22% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ti

  • Titan Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Jul 2026, 1:46PM Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

  • Titan Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    25 Jun 2026, 11:17AM Intimation for loss of shares by shareholder which have already been transferred earlier to Investor Education Protection Fund.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Titan Biotech Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 174.5122 147.2358 135.613 113.0902 92.0429
Liabilities 174.5122 147.2358 135.613 113.0902 92.0429
Equity 8.2637 8.2637 8.2637 8.2637 8.2637
Gross Profit 38.6035 25.4264 34.2814 29.5192 31.1807
Net Profit 27.4472 18.2711 23.6632 21.0248 21.6843
Cash From Operating Activities 30.4208 20.1233 21.1463 21.1783 21.9524
NPM(%) 13.31 11.67 14.42 14.6 17.55
Revenue 206.1903 156.4508 164.0721 143.9993 123.5488
Expenses 167.5868 131.0244 129.7907 114.4801 92.3681
ROE(%) 14.37 9.56 12.38 11 11.35

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Titan Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
GRM Overseas Ltd 87.16 1.44 23.72 2604.30 179.39 0.00
Jain Irrigation Systems Ltd 31.10 10.24 0.00 31854.93 -17.22 0.00
Tierra Agrotech Ltd 60.00 5.15 0.00 2847.09 -7.60 0.00
Kohinoor Foods Ltd 33.05 -1.31 1.43 1609.09 217.58 0.00

Company Info

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Parent Organisation

Titan Biotech Ltd.

Founded

18/02/1992

Managing Director

Mr.Naresh Kumar Singla

NSE Symbol

FAQ